Selection of blockbuster announcements

1. JD.com: revenue in the third quarter increased by 11.4% year-on-year to 243.535 billion yuan, with an adjusted net profit of 10 billion yuan.

$JD.com, Inc.-SW (09618.HK)$Revenue for the third quarter of 2022 was 243.535 billion yuan, an increase of 11.4 percent over the same period last year. The net profit attributable to common shareholders was 6 billion yuan, compared with a net loss of 2.8 billion yuan in the same period last year. Net profit attributable to common shareholders under non-Non-GAAP was 10 billion yuan, compared with 5 billion yuan in the same period last year.

2. JD Logistics, Inc.: the income in the third quarter reached 35.8 billion yuan, an increase of 38.9% over the same period last year.

$JD LOGISTICS (02618.HK)$According to the announcement, in the three months to September 30, 2022, revenue reached 35.771 billion yuan, up 38.9 percent from the same period last year; gross profit was 2.649 billion yuan, up 108.6 percent from the same period last year; and non-international financial reporting standards made a profit of 447 million yuan during the period. As of September 30, 2022, the Group operates more than 1500 warehouses. Including the management area of Yuncang ecological platform, the storage network management area of the group is more than 30 million square meters.

3. Tencent spent HK $352 million to buy back 1.21 million shares on November 18.

$TENCENT (00700.HK)$An announcement was made to buy back 1.21 million shares at a price of HK $292.6-HK $286.6 each at a cost of HK $352 million.

4. Green Leaf Pharmaceutical: LY 03010, a new drug for the treatment of schizophrenia and schizophrenic affective disorder, reaches the preset end point of key clinical trials in the United States.

$LUYE PHARMA (02186.HK)$It was announced that the group's new drug for the treatment of schizophrenia and schizophrenic affective disorder, palmitate sustained release suspension injection (LY 03010), has completed data analysis in key clinical trials conducted in the United States, and the results show that the predetermined end point has been reached, based on the results of previous communication with FDA. LY 03010 plans to submit a new drug marketing application (NDA) to the U.S. Food and Drug Administration (FDA) through 505 (b) (2).

Shanghai Fosun Pharmaceutical: Fubitai bivalent vaccine has been approved for emergency use in Hong Kong, China, for enhanced vaccination for people aged 12 and above.

$FOSUN PHARMA (02196.HK)$According to the Hong Kong government press release on November 18, 2022, the bivalent vaccine against Fubitai's original strain / Omicron mutant BA.4-5 has been approved for emergency use in Hong Kong, China, and can be used for enhanced vaccination for people aged 12 and above. Shanghai Shanghai Fosun Pharmaceutical Industry, a holding subsidiary of Fubitai epidemic Vaccine Company, was authorized by BioNTech SE of Germany in March 2020 to develop and commercialize exclusively in the agreed licensed area.

6. Liqin Resources: the offering price will be HK $15.60 to HK $19.96 per share since November 21.

$LYGEND RESOURCE (02245.HK)$According to the announcement, the company intends to sell 232.5 million shares worldwide, including 23.2548 million shares in Hong Kong and 209.3 million shares in the international offering, with 15 per cent over-allotment options; an offering from November 21 to November 24, 2022, with an expected pricing date of November 24; the offering price will be HK $15.60-19.96 per offer share, with an entry fee of about HK $4032 per lot. China International Capital Corporation and CMB International are co-sponsors and the shares are expected to be listed on the main board of the Stock Exchange on December 1, 2022.

Important matters

CANSINOBIO (06185): purchase a total of 460 million yuan in structural deposits from Pudong Development Bank

Sangao Holdings (00412): Fitch Ratings removes these ratings from the rating Watch status Development (RWE) list

Cathay Pacific (00293): 166% increase in passenger trips from January to October compared with the same period last year

DongFeng Motor Group (00489): Lantu Automobile completed round A financing, with a financing amount of nearly 5 billion yuan.

Gusheng Tang (02273): included in the MSCI China small cap index

China Cinda (01359): approved to issue financial bonds not exceeding 10 billion yuan

Financial data

JD.com 's income in the third quarter increased 11.4% to 243.535 billion yuan compared with the same period last year.

JD Logistics, Inc. (02618) income reached 35.8 billion yuan in the third quarter, up 38.9% from the same period last year.

The net profit of China Xinlianxin Chemical Fertilizer (01866) increased by about 14% to 1.584 billion yuan in the first three quarters compared with the same period last year.

Listing of new shares

Liqin Resources (02245) the initial public offering price is HK $15.60-HK $19.96 per share since November 21st.

Investment and operation

Green Leaf Pharmaceuticals (02186): LY 03010 reaches the preset end point of key clinical trials in the United States

China Xinlianxin Chemical Fertilizer (01866) plans to build a new ecological fertilizer base of one million tons.

Shanghai Fosun Pharmaceutical (02196): Fubitai bivalent vaccine has been approved for emergency use in Hong Kong, China.

Fu Hong Hanlin (02696): Hans-like ®combined with chemotherapy and radiotherapy in EU countries (Spain) was approved to conduct a phase 3 clinical trial for limited small cell lung cancer.

Sichuan Chengdu-Chongqing Expressway (00107) and Shudao Investment signed Construction Project Framework Agreement

COSCO Shipping Holdings (01919) supply chain logistics trailer platform officially put into operation

Increase and decrease holdings

China Longyuan Power Group Corporation (00916) was awarded 11.854 million shares by Blackrock

City of Dreams International Development (00200) lost 1.595 million shares by Southeastern Asset

Zhaojin Mining (01818): the controlling shareholder intends to increase the shares of the company by no more than 2%

DongFeng Motor Group (00489) gets controlling shareholder to increase 8.52 million H shares

Repurchase cancellation

Tencent (00700) spent HK $352 million to buy back 1.21 million shares on November 18th

Great Wall Motor (02333) spent HK $303 million to buy back 30 million shares on November 18th

AIA Group Limited (01299) spent HK $225 million to buy back 2.9456 million shares on November 18th

China Petroleum & Chemical Corporation (00386) spent 59.8473 million yuan to buy back 14 million A shares on November 18.

Haier Smart Home (06690) spent HK $13.411 million to buy back 550000 shares on November 18th

Xiehe New Energy (00182) spent HK $25.8218 million to buy back 39.21 million shares on November 18.